Tristan Degot
Overview
Explore the profile of Tristan Degot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based study
Lortholary O, Garcia-Hermoso D, Sturny-Leclere A, Sitbon K, Nourrisson C, Letscher-Bru V, et al.
Lancet Microbe
. 2024 Oct;
5(11):100907.
PMID: 39395429
Background: Cladophialophora bantiana is one of the most virulent phaeohyphomycetes, typically causes non-angiogenic single (or sometimes multiple) cystic brain lesions, and has resulted in a mortality rate of up to...
2.
Saberianfar S, Degot T, Renaud-Picard B
Transpl Infect Dis
. 2024 Oct;
27(1):e14391.
PMID: 39368081
No abstract available.
3.
Hoang T, Han L, Hirschi S, Degot T, Leroux J, Falcoz P, et al.
Ann Transplant
. 2024 Aug;
29:e944420.
PMID: 39161071
BACKGROUND Lung transplantation (LTx) is a life-extending therapy for specific patients with terminal lung diseases. This study aimed to evaluate the associations and causes of 1-year mortality after lung transplantation...
4.
Hussein M, Gallais F, Degot T, Hirschi S, Leroux J, Riou M, et al.
Respir Med Res
. 2024 Apr;
85:101100.
PMID: 38657294
Introduction: Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at...
5.
Brudon A, Legendre M, Mageau A, Bermudez J, Bonniaud P, Bouvry D, et al.
Eur Respir J
. 2024 Apr;
63(5).
PMID: 38575158
Background: Several rare surfactant-related gene (SRG) variants associated with interstitial lung disease are suspected to be associated with lung cancer, but data are missing. We aimed to study the epidemiology...
6.
Bermudez J, Nathan N, Coiffard B, Roux A, Hirschi S, Degot T, et al.
ERJ Open Res
. 2023 Nov;
9(6).
PMID: 38020562
Background: Interstitial lung disease associated with genetic disorders of the surfactant system is a rare entity in adults that can lead to lung transplantation. Our objective was to describe the...
7.
Moncomble E, Weisenburger G, Picard C, Degot T, Reynaud-Gaubert M, Nieves A, et al.
Respirology
. 2023 Oct;
29(1):71-79.
PMID: 37789612
Background: Antifibrotic agents (AFAs) are now standard-of-care for idiopathic pulmonary fibrosis (IPF). Concerns have arisen about the safety of these drugs in patients undergoing lung transplantation (LTx). Methods: We performed...
8.
Leroux J, Hirschi S, Essaydi A, Bohbot A, Degot T, Schuller A, et al.
Respir Med Res
. 2022 May;
81:100913.
PMID: 35525096
Background: Bronchiolitis obliterans syndrome (BOS) is the main limitation to long-term survival following lung transplantation. Several studies generated promising results regarding the efficacy of extracorporeal photopheresis (ECP) in BOS management....
9.
Bemer P, Peuchant O, Guet-Revillet H, Bador J, Balavoine C, Basille D, et al.
BMC Pulm Med
. 2021 Oct;
21(1):333.
PMID: 34702233
Background: Recent studies report very low adherence of practitioners to ATS/IDSA recommendations for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD), as well as a great variability of practices. Type...
10.
Naccache J, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, et al.
Lancet Respir Med
. 2021 Sep;
10(1):26-34.
PMID: 34506761
Background: The use of cyclophosphamide in patients with acute exacerbation of idiopathic pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and safety of four cyclophosphamide...